These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 7434282)
1. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Haslam PL; Turton CW; Lukoszek A; Salsbury AJ; Dewar A; Collins JV; Turner-Warwick M Thorax; 1980 May; 35(5):328-39. PubMed ID: 7434282 [TBL] [Abstract][Full Text] [Related]
2. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Turner-Warwick M; Haslam PL Am Rev Respir Dis; 1987 Jan; 135(1):26-34. PubMed ID: 3800151 [TBL] [Abstract][Full Text] [Related]
3. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis. Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126 [TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar lavage fluid neutrophils increase after corticosteroid therapy in smokers with idiopathic pulmonary fibrosis. Watters LC; King TE; Cherniack RM; Waldron JA; Stanford RE; Willcox ML; Christopher KL; Schwarz MI Am Rev Respir Dis; 1986 Jan; 133(1):104-9. PubMed ID: 3942366 [TBL] [Abstract][Full Text] [Related]
5. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis. Cailes JB; O'Connor C; Pantelidis P; Southcott AM; Fitzgerald MX; Black CM; du Bois RM Eur Respir J; 1996 May; 9(5):992-9. PubMed ID: 8793462 [TBL] [Abstract][Full Text] [Related]
6. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Hance AJ; Basset F; Saumon G; Danel C; Valeyre D; Battesti JP; Chrétien J; Georges R Ann N Y Acad Sci; 1986; 465():643-56. PubMed ID: 3488004 [TBL] [Abstract][Full Text] [Related]
7. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Rudd RM; Haslam PL; Turner-Warwick M Am Rev Respir Dis; 1981 Jul; 124(1):1-8. PubMed ID: 7258815 [TBL] [Abstract][Full Text] [Related]
8. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. Wallaert B; Hatron PY; Grosbois JM; Tonnel AB; Devulder B; Voisin C Am Rev Respir Dis; 1986 Apr; 133(4):574-80. PubMed ID: 3963625 [TBL] [Abstract][Full Text] [Related]
9. Bronchoalveolar lavage in patients with interstitial lung diseases: side effects and factors affecting fluid recovery. Dhillon DP; Haslam PL; Townsend PJ; Primett Z; Collins JV; Turner-Warwick M Eur J Respir Dis; 1986 May; 68(5):342-50. PubMed ID: 3732429 [TBL] [Abstract][Full Text] [Related]
10. Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis. Haslam PL; Cromwell O; Dewar A; Turner-Warwick M Clin Exp Immunol; 1981 Jun; 44(3):587-93. PubMed ID: 7326869 [TBL] [Abstract][Full Text] [Related]